In vivo anticancer evaluation of 6b, a non-covalent imidazo[1,2-a]quinoxaline-based epidermal growth factor receptor inhibitor against human xenograft tumor innude mice
HIGHLIGHTS who: Zahid Rafiq Bhat and collaborators from the Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and […]